American Peptide Company has announced the expansion of its GMP peptide manufacturing facility in Vista, California.
The facility expansion will increase the company's large-scale peptide production capacity as well as enable it to continue to provide peptides to its growing base of pharmaceutical and biotech customers.
This two-phase expansion encompasses the construction of peptide purification and peptide synthesis suites.
Four additional purification suites will be completed in the first phase and commence operation in April 2009.
This addition will include new HPLC columns and tray lyophilizers.
The second phase of the construction includes two additional large-scale synthesis suites for both solution and solid phase, and completion is forecasted for Q2 in 2009.
This expansion includes the 1,000 L to 2,000 L reactors for solution phase synthesis, in addition to the 260 L to 500 L SPPS for solid phase synthesis.
Storage capacity will be doubled, and a 200 L tray lyophilizer will be installed to accommodate large scale production.
Earlier last year, American Peptide Company introduced its Total Peptide Management programme, a customised service platform designed to help pharmaceutical and life sciences industries bring new drugs to market faster.
The programme offers a portfolio of peptides, value-added services, and consultation to support customer needs as drug products move from discovery to development and commercialisation.
